Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04803682 · ClinicalTrials.gov registry record · Early Phase 1

A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths

A Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
Early Phase 1
Development phase
94
Enrollment target

NCT04803682: Completed Early Phase 1 study, sponsored by M.D. Anderson Cancer Center.

NCT04803682 is a Early Phase 1 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04803682, a Early Phase 1 study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
Early Phase 1
Development phase
94 participants
Enrollment target

Study Summary

This early phase I trial studies how well A Smoking Prevention Interactive Experience (ASPIRE) program and mentorship works in preventing smoking in high school students. ASPIRE is an online-based, youth-centered tobacco prevention and cessation program. The goal of this research study is to learn if training eleventh grade high school students to be tobacco-free role models and mentors for ninth grade high school students is possible and will positively influence the younger peers.

Interventions

  • BEHAVIORAL Questionnaire Administration
  • BEHAVIORAL Preventive Intervention

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2016-01-08
Est. Completion 2021-03-16
Phase Early Phase 1

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT04803682

The ClinicalTrials.gov registry entry for NCT04803682 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Questionnaire Administration is the first listed.

NCT04803682 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04803682 about?

NCT04803682 is a clinical study titled "A Smoking Prevention Program (ASPIRE) and Mentoring for Preventing Smoking Among High School Youths". This early phase I trial studies how well A Smoking Prevention Interactive Experience (ASPIRE) program and mentorship works in preventing smoking in high school students. ASPIRE is an online-based, youth-centered tobacco prevention and cessation program. The goal of this research study is to learn i...

What is the current status of trial NCT04803682?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 94 participants. The study started on 2016-01-08. Estimated completion is 2021-03-16.

What interventions are being tested in trial NCT04803682?

The interventions under investigation include: Questionnaire Administration (BEHAVIORAL), Preventive Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT04803682?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.